Scarica l'app Stockscreener
15.21
3.80%
-0.60
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Assembly Biosciences Inc Borsa (ASMB) Ultime notizie
Assembly Biosciences (NASDAQ:ASMB) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Gilead raises Assembly Bio stake to ~30% - MSN
Gilead invests in Assembly Bio to advance clinical programs - The Pharma Letter
Gilead boosts stake in Assembly Bio with $30.1 million investment By Investing.com - Investing.com Canada
Assembly Biosciences strikes amended deal with Gilead - Investing.com
Assembly Biosciences strikes amended deal with Gilead By Investing.com - Investing.com UK
Assembly Bio stock rises as Gilead ups stake (ASMB:NASDAQ) - Seeking Alpha
Assembly Biosciences Shares Rise 19% After Gilead Investment, Funding - MarketWatch
Assembly Biosciences Gets $30.1M Equity Investment, Funding From Gilead - MarketWatch
Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs - The Manila Times
Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from - The Bakersfield Californian
Assembly Bio Secures $30.1M Gilead Investment, Advancing Ambitious Antiviral Pipeline - StockTitan
(ASMB) Trading Advice - Stock Traders Daily
Assembly Biosciences, Inc. (NASDAQ:ASMB) Sees Significant Growth in Short Interest - MarketBeat
Reviewing BeiGene (NASDAQ:BGNE) and I-Mab (NASDAQ:IMAB) - Defense World
How the (ASMB) price action is used to our Advantage - Stock Traders Daily
Assembly Biosciences, Inc. (NASDAQ:ASMB) Sees Large Increase in Short Interest - MarketBeat
Assembly Biosciences investor Alexander Schornstein buys $372,994 in shares By Investing.com - Investing.com
Novavax and Assembly lead infectious disease gainers in 2024 - BioWorld Online
Comparing Cardiol Therapeutics (NASDAQ:CRDL) & Gilead Sciences (NASDAQ:GILD) - Defense World
Genome Editing Market Size Projected to Reach USD 32.72 - GlobeNewswire
Assembly Biosciences Reports Q3 2024 Financials and Strategic Advances - TipRanks
(ASMB) Pivots Trading Plans and Risk Controls - Stock Traders Daily
ARMISTICE CAPITAL, LLC Adjusts Stake in Assembly Biosciences Inc - GuruFocus.com
HC Wainwright Has Optimistic Outlook of ASMB FY2024 Earnings - MarketBeat
Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Down 51.2% in October - MarketBeat
Analysts Just Slashed Their Assembly Biosciences, Inc. (NASDAQ:ASMB) EPS Numbers - Simply Wall St
Bearish: Analysts Just Cut Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Revenue and EPS estimates - Yahoo Finance
Analyzing Taysha Gene Therapies (NASDAQ:TSHA) & Gilead Sciences (NASDAQ:GILD) - Defense World
Assembly Biosciences: Q3 Earnings Snapshot - CTPost
Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates - The Manila Times
Assembly Biosciences initiates at-the-market equity program - Investing.com India
Assembly Biosciences Inc (ASMB) Reports Q3 2024 Revenue of $6.8M, GAAP EPS Loss of $1.51, Misses Estimates - GuruFocus.com
Marquis Who's Who Honors Jonathan Colon, PhD, for Expertise in Biotechnology - 24-7 Press Release
Assembly Biosciences (NASDAQ:ASMB) Stock Crosses Above 200-Day Moving AverageShould You Sell? - MarketBeat
When (ASMB) Moves Investors should Listen - Stock Traders Daily
Baker Lab’s AI-Driven Antibody Cage Technology Unlocked as Archon Biosciences - Genetic Engineering & Biotechnology News
Short Interest in Assembly Biosciences, Inc. (NASDAQ:ASMB) Declines By 7.9% - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Share Price Crosses Above 200 Day Moving AverageHere's Why - MarketBeat
(ASMB) Investment Analysis and Advice - Stock Traders Daily
Microbiome Manufacturing Market Poised for Robust Growth at 15.4% CAGR by 2031 - WhaTech
Assembly Biosciences (NASDAQ:ASMB) Shares Pass Above 200-Day Moving AverageTime to Sell? - MarketBeat
Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Update - MarketBeat
Assembly Biosciences, Inc.'s (NASDAQ:ASMB) market cap surged US$16m last week, individual investors who have a lot riding on the company were rewarded - Simply Wall St
Assembly Biosciences sees major stock purchase by investor Alexander Schornstein By Investing.com - Investing.com Canada
Alexander Schornstein Purchases 10,000 Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB) Stock - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Share Price Crosses Above 200-Day Moving AverageTime to Sell? - MarketBeat
Assembly Biosciences CEO sells shares worth $2,917 to cover taxes By Investing.com - Investing.com South Africa
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):